These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7995072)

  • 41. Painless Acanthamoeba Keratitis with Normal Vision.
    Kwok PW; Kam KW; Jhanji V; Young AL
    Optom Vis Sci; 2017 Mar; 94(3):432-435. PubMed ID: 27870779
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acanthamoeba keratitis: report of three cases.
    Maudgal PC
    Bull Soc Belge Ophtalmol; 1989; 231():135-48. PubMed ID: 2488446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Should we be using polyhexamethylene biguanide to treat Acanthamoeba keratitis?
    Kumar B; Crawford GJ
    Aust N Z J Ophthalmol; 1997 May; 25(2):94-5. PubMed ID: 9267593
    [No Abstract]   [Full Text] [Related]  

  • 44. Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management.
    Moore MB; McCulley JP
    Br J Ophthalmol; 1989 Apr; 73(4):271-5. PubMed ID: 2540794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis.
    Elder MJ; Kilvington S; Dart JK
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1059-64. PubMed ID: 8125716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Acanthamoeba keratitis: about the first two Tunisian cases].
    Ben Salah S; Makni F; Cheikrouhou F; Ben Zina Z; Mlik M; Feki J; Colin J; Ayadi A
    Bull Soc Pathol Exot; 2007 Feb; 100(1):41-2. PubMed ID: 17402694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
    Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
    Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Acanthamoeba keratitis].
    Eggink CA; Vaandrager W; Burger DM; Sauerwein RW
    Ned Tijdschr Geneeskd; 1996 May; 140(21):1130-33. PubMed ID: 8692340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acanthamoeba keratitis during orthokeratology.
    Wilhelmus KR
    Cornea; 2005 Oct; 24(7):864-6. PubMed ID: 16160506
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Amoebas of the genus acanthamoeba as an etiological factor of keratitis].
    Kosik-Bogacka D; Czepita D; Łanocha N
    Klin Oczna; 2010; 112(4-6):161-4. PubMed ID: 20825074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-contact lens use-related Acanthamoeba keratitis in southern Turkey: evaluation of risk factors and clinical features.
    Erdem E; Evcil Y; Yagmur M; Eroglu F; Koltas S; Ersoz R
    Eur J Ophthalmol; 2014; 24(2):164-72. PubMed ID: 24030538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain.
    Lorenzo-Morales J; Morcillo-Laiz R; Martín-Navarro CM; López-Vélez R; López-Arencibia A; Arnalich-Montiel F; Maciver SK; Valladares B; Martínez-Carretero E
    Cont Lens Anterior Eye; 2011 Apr; 34(2):83-6. PubMed ID: 21130679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide.
    Murdoch D; Gray TB; Cursons R; Parr D
    Aust N Z J Ophthalmol; 1998 Aug; 26(3):231-6. PubMed ID: 9717755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus.
    Carrijo-Carvalho LC; Sant'ana VP; Foronda AS; de Freitas D; de Souza Carvalho FR
    Surv Ophthalmol; 2017; 62(2):203-218. PubMed ID: 27836717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis.
    Gueudry J; Le Goff L; Compagnon P; Lefevre S; Colasse E; Aknine C; Duval F; François A; Razakandrainibe R; Ballet JJ; Muraine M; Favennec L
    J Antimicrob Chemother; 2018 Jul; 73(7):1895-1898. PubMed ID: 29596605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of In Vitro Antiamoebic Activity of Antimicrobial Agents Against Clinical Acanthamoeba Isolates.
    Nakaminami H; Tanuma K; Enomoto K; Yoshimura Y; Onuki T; Nihonyanagi S; Hamada Y; Noguchi N
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):629-634. PubMed ID: 28704121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment with a derivative of propamidine for keratitis in a user of soft lenses].
    Martín Sánchez AM; de la Cuesta López A; de Miguel Martínez I; Llona Colino G
    Med Clin (Barc); 1992 Oct; 99(14):558-9. PubMed ID: 1434995
    [No Abstract]   [Full Text] [Related]  

  • 59. In vitro amoebicidal activity of propamidine and pentamidine isethionate against Acanthamoeba species and toxicity to corneal tissues.
    Alizadeh H; Silvany RE; Meyer DR; Dougherty JM; McCulley JP
    Cornea; 1997 Jan; 16(1):94-100. PubMed ID: 8985640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is polyhexamethylene biguanide alone effective for Acanthamoeba keratitis?
    Tseng SH; Lin SC; Chen FK
    Cornea; 1998 May; 17(3):345-6. PubMed ID: 9603394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.